Kyle Carver - Nov 5, 2025 Form 4 Insider Report for Evommune, Inc. (EVMN)

Role
Chief Financial Officer
Signature
/s/ Gregory S. Moss, Attorney-in-Fact
Stock symbol
EVMN
Transactions as of
Nov 5, 2025
Transactions value $
$0
Form type
4
Date filed
11/7/2025, 04:15 PM
Previous filing
Nov 9, 2021
Next filing
Nov 12, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carver Kyle Chief Financial Officer C/O EVOMMUNE, INC., 1841 PAGE MILL ROAD, SUITE 100, PALO ALTO /s/ Gregory S. Moss, Attorney-in-Fact 2025-11-07 0001757072

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVMN Employee Stock Option (Right to Buy) Award $0 +279K $0.00 279K Nov 5, 2025 Common Stock 279K $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth (1/4) of the shares subject to the option award shall vest on November 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.